Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14734451 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients
Condition: Stage IV Melanoma
Intervention: Drug: Coxsackievirus A21

Indicates status has not been verified in more than two years